Clinical Trial of Concomitant Hip Arthroscopy During PAO
Single-Blind Randomized Clinical Trial of Concomitant Hip Arthroscopy During Periacetabular Osteotomy for the Management of Hip Dysplasia
Mayo Clinic
106 participants
Aug 23, 2017
INTERVENTIONAL
Conditions
Summary
The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
Eligibility
Inclusion Criteria5
- Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment
- Skeletally mature
- Age 15 - 55
- Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis)
- Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip
Exclusion Criteria4
- Pregnant women
- Previous surgery about the hip
- Patients receiving PAO for acetabular retroversion in the absence of DDH
- Previous hip arthroscopy to address intra-articular pathology
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Bernese periacetabular osteotomy has become the osteotomy of choice in North America for correction of the dysplastic hip. The ability to position the acetabular component in a specifically desired position for each individual patient improves joint biomechanics, restores joint balance and stability, and offloads the structures at risk for damage such as the labrum and the adjacent articular cartilage.
An intraarticular assessment with hip arthroscopy (HA) at the time of periacetabular osteotomy allows the surgeon to assess and treat the associated labral and chondral pathology and allows the surgeon to treat abnormalities of the femoral head junction.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03181048